News
DURHAM, NC, USA and BEIJING, China I July 3, 2025 I Brii Biosciences Limited ("Brii Bio," stock code: 2137.HK), a biotechnology company developing ...
BEIJING, China I July 03, 2025 I InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
BOSTON, MA, USA I July 02, 2025 I Modella AI, a leader in artificial intelligence for life sciences, today announced a multi-year agreement with AstraZeneca.
First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week Phase IIa study of small ...
MONTREAL, Canada I July 02, 2025 I Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage ...
EMERYVILLE, CA, USA I July 02, 2025 I 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing ...
Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco’s data package and related intellectual property for monepantel to develop and commercialise NUZ-001 and its related ...
EAST HANOVER, NJ, USA I July 3, 2025 I Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in ...
BEIJING, SHANGHAI, China and BOSTON, MA, USA I July 2, 2025 I Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug ...
HONG KONG, China I July 3, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase ...
BENGALURU, India I July 3, 2025 I Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today ...
RAHWAY, NJ, USA I July 02, 2025 I Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results